SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kimia Biosciences informs about press release

19 Feb 2026 Evaluate
Kimia Biosciences has informed that it enclosed copies of Newspaper Publications published in Financial Express (English) and Jansatta (Hindi) on Thursday, 19th February, 2026 regarding the dispatch of Postal Ballot Notice and remote e-voting information for seeking approval of the members of the Company by way of postal ballot for special business as set out in the Notice of postal ballot through email. The aforesaid Newspaper advertisement is also available on the website of the Company at www.kimiabiosciences.com

The above information is a part of company’s filings submitted to BSE.

Kimia Biosciences Share Price

36.30 1.25 (3.57%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×